🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 10 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/04/2025 | 284,12 | 287,75 | 278,89 | 284,82 | +0,18% | 3,12% | 489.400 |
| 14/04/2025 | 285,16 | 286,98 | 278,40 | 284,31 | +1,12% | 3,01% | 444.500 |
| 11/04/2025 | 283,29 | 285,09 | 276,39 | 281,16 | +0,81% | 3,07% | 670.800 |
| 10/04/2025 | 285,88 | 287,44 | 269,93 | 278,89 | -4,74% | 6,12% | 595.800 |
| 09/04/2025 | 275,55 | 294,63 | 266,98 | 292,78 | +4,68% | 10,03% | 584.400 |
| 08/04/2025 | 299,08 | 304,81 | 275,94 | 279,69 | -4,12% | 9,65% | 551.700 |
| 07/04/2025 | 284,55 | 299,07 | 273,12 | 291,72 | -0,25% | 9,12% | 626.200 |
| 04/04/2025 | 302,83 | 308,10 | 290,33 | 292,46 | -4,85% | 5,87% | 579.500 |
| 03/04/2025 | 300,00 | 312,14 | 298,00 | 307,36 | -1,57% | 4,71% | 431.900 |
| 02/04/2025 | 303,78 | 313,41 | 303,15 | 312,26 | +1,75% | 3,38% | 461.000 |
| 01/04/2025 | 308,17 | 311,55 | 303,33 | 306,88 | -0,45% | 2,67% | 576.700 |
| 31/03/2025 | 303,77 | 309,64 | 298,60 | 308,27 | +0,42% | 3,63% | 611.800 |
| 28/03/2025 | 309,58 | 309,58 | 304,03 | 306,97 | -0,34% | 1,79% | 223.200 |
| 27/03/2025 | 311,87 | 318,40 | 307,57 | 308,02 | -0,90% | 3,47% | 302.800 |
| 26/03/2025 | 313,72 | 315,42 | 309,99 | 310,82 | -1,87% | 1,73% | 325.100 |
| 25/03/2025 | 322,32 | 322,32 | 312,38 | 316,73 | -0,98% | 3,08% | 345.500 |
| 24/03/2025 | 313,18 | 320,67 | 313,18 | 319,86 | +2,19% | 2,39% | 376.100 |
| 21/03/2025 | 311,18 | 315,69 | 308,43 | 312,99 | -0,19% | 2,33% | 1.155.300 |
| 20/03/2025 | 315,52 | 319,48 | 312,61 | 313,60 | -1,65% | 2,18% | 330.900 |
| 19/03/2025 | 315,17 | 319,07 | 307,64 | 318,85 | +1,51% | 3,63% | 539.300 |
| 18/03/2025 | 322,32 | 324,57 | 313,98 | 314,12 | -2,73% | 3,29% | 418.000 |
| 17/03/2025 | 307,86 | 324,22 | 304,55 | 322,94 | +5,11% | 6,39% | 400.600 |
| 14/03/2025 | 305,06 | 310,17 | 305,06 | 307,24 | +0,61% | 1,68% | 494.800 |
| 13/03/2025 | 306,88 | 307,98 | 299,47 | 305,39 | -0,55% | 2,77% | 444.200 |
| 12/03/2025 | 304,22 | 307,73 | 301,25 | 307,09 | +0,88% | 2,13% | 723.300 |
| 11/03/2025 | 314,74 | 318,06 | 303,62 | 304,42 | -4,23% | 4,59% | 553.500 |
| 10/03/2025 | 313,93 | 323,99 | 313,93 | 317,87 | +0,62% | 3,20% | 436.100 |
| 07/03/2025 | 307,15 | 320,81 | 306,11 | 315,91 | +2,67% | 4,79% | 740.100 |
| 06/03/2025 | 309,06 | 311,87 | 305,00 | 307,68 | -1,06% | 2,22% | 423.100 |
| 05/03/2025 | 307,40 | 312,86 | 306,49 | 310,98 | +0,77% | 2,07% | 479.500 |